New cancer clinical trial: A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

Published on: October 01, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share